Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision MedicineREAD THE PR

Proscia study – AI can predict diagnostic concordance for melanoma

Proscia
By Author Proscia | November 1, 2022

In addition to this study, Proscia plans to conduct additional research illustrating the potential benefits of AI in helping pathologists to diagnose melanoma, including lowering the misdiagnosis rate, accelerating turnaround times for critical results, reducing costs and distress for patients.

Our website uses cookies. By using this site, you agree to its use of cookies.